Does the risk of cerebral palsy increase or decrease with increasing gestational age?

K S Joseph1, Alexander C Allen, Samawal Lutfi

  • 1Perinatal Epidemiology Research Unit, Departments of Obstetrics & Gynecology and of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada. kjoseph@dal.ca

Insights

The risk of cerebral palsy (CP) increases with gestational age when considering fetuses at risk, not just live births. This new perspective reframes understanding and prevention of CP.

Area of Science:

  • Epidemiology
  • Perinatal Medicine
  • Developmental Neuroscience

Background:

  • Cerebral palsy (CP) is traditionally linked to live birth gestational age.
  • Prenatal factors like malformations, vascular insults, and maternal infection suggest CP originates before birth.
  • Viewing CP as a fetal condition offers new epidemiological insights.

Purpose of the Study:

  • To explore the epidemiologic implications of viewing cerebral palsy (CP) as a fetal condition.
  • To re-evaluate gestational age-specific CP rates using a "fetuses-at-risk" model.
  • To compare conventional and alternative epidemiological formulations for CP.

Main Methods:

  • Utilized published data from Shiga Prefecture, Japan, and North-East England.
  • Calculated conventional gestational age-specific CP rates per live birth.
  • Calculated alternative "fetuses-at-risk" CP rates per fetus at risk for a given gestation.

Main Results:

  • Conventional rates showed decreasing CP risk with increasing gestational age.
  • The "fetuses-at-risk" approach revealed increasing CP risk with longer gestational duration.
  • Rates shifted from 63.9/1,000 live births (<28 weeks) to 0.9/1,000 (≥37 weeks) conventionally.
  • Rates shifted from 0.08/1,000 fetuses (<28 weeks) to 0.9/1,000 (≥37 weeks) using the alternative model.

Conclusions:

  • The "fetuses-at-risk" model is the appropriate epidemiological approach for causal analysis of CP.
  • This formulation demonstrates that CP risk escalates with increased gestational duration.
  • This perspective may redirect research toward understanding and preventing CP more effectively.

Related Concept Videos

Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
44.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K